BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23373995)

  • 1. Low concentrations of Rhodamine-6G selectively destroy tumor cells and improve survival of melanoma transplanted mice.
    Kutushov M; Gorelik O
    Neoplasma; 2013; 60(3):262-73. PubMed ID: 23373995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
    Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
    Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Rhodamine 6G (C.I. Basic Red 1) (CAS No. 989-38-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 364():1-192. PubMed ID: 12692640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodamine 6G, inhibitor of both H+-ejections from mitochondria energized with ATP and with respiratory substrates.
    Higuti T; Niimi S; Saito R; Nakasima S; Ohe T; Tani I; Yoshimura T
    Biochim Biophys Acta; 1980 Dec; 593(2):463-7. PubMed ID: 7236646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
    Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
    Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.
    Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Marín-Hernández A; Ruiz-Azuara L; Moreno-Sánchez R
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):208-17. PubMed ID: 16580038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rhodamine 6G on the mitochondrial ultrastructure of mouse spermatocytes.
    Zhang WW; Hood RD; Smith-Sommerville HE
    Toxicol Lett; 1990 Mar; 51(1):35-40. PubMed ID: 2315957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells.
    Youn MJ; Kim JK; Park SY; Kim Y; Park C; Kim ES; Park KI; So HS; Park R
    J Ethnopharmacol; 2009 Jan; 121(2):221-8. PubMed ID: 19041933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumour effect of total saponins of Rubus parvifolius on malignant melanoma].
    Zheng ZX; Zhang LJ; Huang CX; Huang QL; Wei XD; Wu XY; Zhou WM
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2055-8. PubMed ID: 18161304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of rat brain protein kinase C by rhodamine 6G. Profound effects of the lipid cofactor on the inhibition of the enzyme.
    O'Brian CA; Weinstein IB
    Biochem Pharmacol; 1987 Apr; 36(8):1231-5. PubMed ID: 3109437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser dyes for experimental phototherapy of human cancer: comparison of three rhodamines.
    Haghighat S; Castro DJ; Lufkin RB; Fetterman HR; Castro DJ; Soudant J; Ward PH; Saxton RE
    Laryngoscope; 1992 Jan; 102(1):81-7. PubMed ID: 1731162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of in vivo and in vitro exposure to rhodamine dyes on mitochondrial function of mouse embryos.
    Ranganathan S; Hood RD
    Teratog Carcinog Mutagen; 1989; 9(1):29-37. PubMed ID: 2567067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism.
    Giammarioli AM; Maselli A; Casagrande A; Gambardella L; Gallina A; Spada M; Giovannetti A; Proietti E; Malorni W; Pierdominici M
    Cancer Res; 2008 Jul; 68(13):5291-300. PubMed ID: 18593930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice.
    Wang H; Ke M; Tian Y; Wang J; Li B; Wang Y; Dou J; Zhou C
    Eur J Pharmacol; 2013 May; 707(1-3):1-10. PubMed ID: 23541725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
    Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
    Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tunable cytotoxicity of rhodamine 6G via anion variations.
    Magut PK; Das S; Fernand VE; Losso J; McDonough K; Naylor BM; Aggarwal S; Warner IM
    J Am Chem Soc; 2013 Oct; 135(42):15873-9. PubMed ID: 24059469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.
    López-Fauqued M; Gil R; Grueso J; Hernandez-Losa J; Pujol A; Moliné T; Recio JA
    Int J Cancer; 2010 Apr; 126(7):1549-61. PubMed ID: 19810100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the growth rate of the Walker 256 tumor in rats by rhodamine 6G together with hypoglycemia.
    Fearon KC; Plumb JA; Burns HJ; Calman KC
    Cancer Res; 1987 Jul; 47(14):3684-7. PubMed ID: 3594433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.